Dear Colleagues,
We recently made an exciting announcement at Bioventus Inc., and filed a Registration Statement on Form S-1 with the Securities and Exchange Commission (“SEC”), with respect to a proposed initial public offering or “IPO.” While this filing is no guarantee that we will become a publicly traded company, we are hopeful that in the next several weeks we will achieve this milestone.
You should know that the SEC’s rules restrict what we can say publicly about the company for the next several weeks. These restrictions will remain in effect until the SEC declares our Registration Statement effective and our shares are sold in the IPO. Therefore, you should not say anything publicly (including to media, family, friends, distributors, end-users or suppliers) regarding the filing, Bioventus’ business, growth, financial health, future or outlook.
The SEC deems certain statements to be illegal selling efforts and any comments like that could jeopardize our IPO and lead to liability. If you are asked about the filing by anyone outside the company, including media, a distributor or end-user you should say that the company is in a restricted period and you cannot comment further at this time.
Our announcement is likely to draw interest from the financial community and the media as well, so it is particularly important for us to speak with one voice. If you receive any external inquiries about the IPO from media or analysts please send them to Greg Anglum and Tom Hill.
When it comes to the day-to-day operations of our company, it should remain business as usual and you should continue to perform your duties as you did before this announcement. Please read the attached important information regarding employee do’s and don’ts and Q & A’s.
Thank you,
Ken